Opening date: December 16, 2019 - Closing date: February 28, 2020 at 1 PM (CET)
Worldwide, infectious diseases are a on the rise and endanger the health and the life of humans and animals. Concurrently, antibiotics are rapidly losing their effectiveness, as bacteria are developing resistance to them. Due to the continuous spread of antimicrobial resistance (AMR), the treatment of an increasing numbers of bacterial infections has become difficult and might even become impossible.
Antimicrobial resistance affects not only humans but is tightly connected to animal health and the environment. The frequent transmission between habitats accelerates the spread of AMR, evoking new challenges that can only be solved in a holistic approach. Hence, to tackle the AMR problem in a comprising and sustainable manner, it is vital to intensify the exchange of information and the cooperation between human and veterinary medicine and other areas of expertise like biology, chemistry, agricultural sciences, environmental research, food technology and social sciences.
The World Health Organization (WHO) has adopted a global action plan on AMR in 2015, emphasizing the “One Health” approach. After the UN High-Level Meeting on AMR in 2016, the Secretary-General of the United Nations convened the Interagency Coordination Group on Antimicrobial Resistance. The European Commission has established the European “One Health” Action Plan against AMR in 2017. In 2019, the G20 leaders declared that the member states will accelerate efforts based on a “One-Health” approach to combat AMR.
To master the challenge of containing AMR, it is essential to overcome national borders and coordinate R&D activities jointly. France and Germany, who are actively involved in several international initiatives to fight AMR, have adopted this one health approach. In this joint bilateral cooperation, both countries combined their resources and expertise to tackle AMR.
With this call for project proposals and the subsequent funding of selected projects, the German Federal Ministry of Education and Research (BMBF) and the French Ministry of Higher Education, Research and Innovation (MESRI) want to encourage and enable French and German scientists to collaborate intensively and effectively in multidisciplinary and synergistic research projects on AMR. The results of the projects shall support the alignment of public health policies and/or measures to fight AMR.
The topics of this call were identified and prioritized by a German-French expert committee, concentrating on knowledge gaps in the occurrence, spread, containment and reduction of AMR, as well as focusing on the scientific strengths of each of the two countries. Accordingly, the first topic addresses AMR in environmental reservoirs, and the second topic focuses on colonization of humans, farm animals, pets and food products by antibiotic resistant bacteria. Research projects on both topics can include all suitable methods of all scientific fields, for instance (but not limited to) epidemiological methods like phenotyping, genotyping, statistical modelling, and/or methods of social and economic sciences.
Clinical research projects utilising existing biobanks and/or well-established cohorts are included, however, the recruitment of patients is beyond the scope of the call.
Projects may cost up to one million Euro and require up to 3 years.
Eligible expenses will respectively be funded by MESRI and BMBF, according to the specific national rules.
To be eligible for this call, a project proposal must adhere to all common eligibility criteria, which are put forth jointly by the two funding agencies, as well as to specific national requirements, which are listed in annex 1:
The evaluation criteria are:
In this bilateral programme, the scientific necessity and the added benefit of the French-German cooperation to the project is of critical importance. Particular attention will be given to the integrated nature of a project, from the planning and design stages to the methods of implementation. To be considered for funding, proposals have to convincingly demonstrate the benefits of the French-German interactions, particularly as they relate to the binational project coordination and common work arrangements.
Each coordinator (PI) will have to report to his/her respective funding agency according to the provisions of the funding agreement.
A joint kick-off meeting and a joint final review meeting of all funded projects will be organized in Germany and in France, respectively. The participation of each consortium is mandatory and a budget should be foreseen accordingly in the budget proposal of the project.
Funding Organisation |
French Ministry of Higher Education, Research and Innovation (MESRI)/Agence Nationale de la Recherche (ANR); |
Initial funding pre-commitment |
Approx. 3.500.000 € (French funding) Anticipated number of funded joint projects: 6-8 |
National Contact Point |
Dr. Ingrid Pfeifer Phone : +33 (0)1 78 09 80 22 E-Mail: ingrid.pfeifer@agencerecherche.fr Health & Biology Department; Agence Nationale de la Recherche –ANR; 50, avenue Daumesnil - 75012 Paris, France |
Eligible institutions |
The consortium must include at least one French research partner **and one German research partner and is open to partners from the "public research organisations or related-one" and/or partners from the "commercial company" type*. ** Partners that have their primary establishment in France and/or Partners established in the EU and that can prove that they have a secondary establishment in France * Include public law entities engaged in research activity and private law entities engaged in research and/or teaching activity. Please refer to ANR’s financial regulations regarding the rates of support for different partners (“Règlement financier ANR”): |
Additional eligibility criteria |
ANR will not allow double funding and will not finance projects or parts of projects that have been funded through other calls. |
Eligible costs |
Among others, eligible costs include personnel costs for temporary contracts; small equipment; consumables and animal costs; travel; and sub-contracting, if necessary to carry out the proposed activities. Please note that at ANR, the eligible overhead rates (indirect costs) vary depending on the type of partner applying for funding. Please refer to ANR’s financial regulations (“Règlement financier ANR”) for full details at: http://www.agence-nationale-recherche.fr/RF ANR has a maximum funding per applicant for this call: each applicant can be funded with a maximum amount of 250 000 €. There is equally a minimum amount per applicant: 15 000 €. |
Further guidance |
Please see online the specific annex documents for research groups applying to this call for proposals for funding in France, available via a link on the site of the publication of the call on the ANR site: http://anr.fr/ANR-FRDE-AMR-2020 |
Funding Organisation |
Federal Ministry of Education and Research (BMBF) https://www.bmbf.de/ |
Initial funding pre-commitment |
Approx. 3.500.000 € (German funding) Anticipated number of funded joint projects: 6-8 |
National Contact Point |
Dr. Christiane Juhls Communication Systems, Human-Machine-Interaction, Health VDI/VDE Innovation + Technik GmbH Steinplatz 1 10623 Berlin Germany Phone: +49 (0) 30 310078-498 |
Eligible institutions |
Eligible institutions: Public and private universities and universities of applied science, non-university research institutions (FhG, MPG, HGF, WGL), university hospitals and companies in the industrial sector with R & D capacity in Germany. |
Additional eligibility criteria |
The expertise and infrastructure required for the realization of the project has to be demonstrated. Business enterprises can only be promoted if the financial standing of the company is guaranteed for the project duration. |
Eligible costs |
All costs related to the project, which are not covered by basic financing, are eligible. This includes personal costs, consumables, travel costs, in exceptional cases investments, publication costs, subcontracts and other expenses. The respective funding rates are linked to national regulations, please refer to the national call text. |
Further guidance |
Further information and national regulations are available in the German call text. Additionally, German applicants are advised to refer to the German call text and to contact their respective national contact point. https://www.gesundheitsforschung-bmbf.de/de/zweite-Foerderrichtlinie-dt-frz-AMR-Projekte.php |